New Funding Opportunities Availble Through the Department of Defense
Department of Defense Peer Reviewed Medical Research Program
Funding Opportunities for Fiscal Year 2011
The Peer Reviewed Medical Research Program (PRMRP) was established in
1999 to provide support for military health-related research of
exceptional scientific merit. Appropriations for the PRMRP from Fiscal
Year 1999 (FY99) through FY10 (excluding FY07, in which no appropriation
was made) totaled $494.5 million (M). The FY11 appropriation is $50M.
The vision of the FY11 PRMRP is to improve the health and well-being of
all military service members, veterans, and beneficiaries. Through four
different award mechanisms, the PRMRP challenges the scientific and
clinical communities to address one of the FY11 congressionally directed
topic areas with original ideas that foster new directions in basic
science and translational research; novel product development leading to
improved therapeutic or diagnostic tools, or improvements in clinical
policies/guidelines; or clinical trials that address an immediate
clinical need. The FY11 PRMRP seeks applications in laboratory,
clinical, behavioral, and epidemiologic research as well as public
health and policy; environmental sciences; nursing; occupational health;
alternative therapies; ethics; and economics.
All applications for PRMRP funding must specifically address at least
one of the topic areas as directed by Congress, and must be directly
relevant to the health care needs of the military service members,
veterans, and/or beneficiaries. If the proposed research is not relevant
to FY11 PRMRP topic areas, the Government reserves the right to
administratively withdraw the application. The Government also reserves
the right to reassign the application’s topic area if submitted under an
inappropriate topic area. The FY11 PRMRP topic areas are listed below.
Chronic fatigue syndrome , Chronic migraine and post-traumatic headache,
Drug abuse, Epidermolysis bullosa, Epilepsy, Fragile X syndrome,
Inflammatory bowel disease, Interstitial cystitis, Listeria vaccine for
infectious disease, Lupus, Neuroblastoma, Osteoporosis and related bone
disease, Paget’s disease, Pancreatitis, Pheochromocytoma, Polycystic
kidney disease, Posttraumatic osteoarthritis, Scleroderma, Social work
research, and Tinnitus
Please use the following link to retrieve the eligibility requirements,
deadlines and additional details for each award mechanism.
http://cdmrp.army.mil/funding/prmrp.shtml
Discovery Award – Maximum funding $125K for direct costs
*Supports the exploration of a highly innovative new concept or untested
theory
*Projects involving human subjects or specimens will not be supported
unless they are exempt under Title 32, Code of Federal Regulations, Part
219, Section 101(b)(32 CFR 219.101[b])
Clinical Trial Award – Maximum funding $2.2M for direct costs
*Supports the rapid implementation of clinical trials of novel
interventions with the potential to have a significant impact of patient
care in the topic are of interest
*Investigation New Drug or Investigational Device Exemption applications
should be submitted before application submission
*Clinical trial is expected to be initiated within 12 months of award
date
Investigator-Initiated Research Award – Maximum funding $750K for direct
costs
*Supports research that will make an original and important contribution
to the field of research or patient care in the topic area of interest
*Partnering Principal Investigator option available
*Clinical trials will not be funded
Technology/Therapeutic Development Award – Maximum funding $1.5M for
direct costs
*Supports the development of new diagnostics or therapies that have the
potential to make a strong impact on patient care in the topic area of
interest
*Product-oriented
oDevice
oDrug
oClinical guidance/guidelines
*Clinical trials will not be funded
All applications must conform to the program announcements and
application instructions that are available for electronic downloading
from the Grants.gov website. The application package containing the
required forms for each award mechanism will also be found on
Grants.gov. A listing of all USAMRMC funding opportunities can be
obtained on the Grants.gov website by performing a basic search using
CFDA Number 12.420.
A pre-application will be required and must be submitted through the
CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application
deadline. Applications must be submitted through the federal
government’s single-entry portal, Grants.gov. Requests for email
notification of the program announcements release may be sent to
help@cdmrp.org. For more information about the PRMRP or other
CDMRP-administered programs, please visit the CDMRP website
(http://cdmrp.army.mil).
Points of Contact:
CDMRP Public Affairs
301-619-9783
CDMRP.PublicAffairs@amedd.army.mil
